Sources | Names Used |
---|---|
CTRPv2 | selumetinib:navitoclax (8:1 mol/mol) |
PharmacoGx | selumetinib:navitoclax (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ETV6 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-13 |
mRNA | NRROS | CTRPv2 | pan-cancer | AAC | 0.34 | 4e-13 |
mRNA | IRF2BP2 | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-12 |
mRNA | GRAMD4 | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-11 |
mRNA | ZFP36L2 | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-11 |
mRNA | C16orf87 | CTRPv2 | pan-cancer | AAC | -0.23 | 6e-10 |
mRNA | ASB3 | CTRPv2 | pan-cancer | AAC | -0.23 | 9e-10 |
mRNA | LGALS9 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-09 |
mRNA | PRPS1 | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-09 |
mRNA | TSNARE1 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |